$PTOS
P2 Solar, Inc.

2023 Q3 Form 10-Q Financial Statement

#000164033423001561 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023 Q1
Revenue $92.40K $39.67K
YoY Change
Cost Of Revenue $49.86K $17.93K
YoY Change
Gross Profit $42.54K $21.74K
YoY Change
Gross Profit Margin 46.04% 54.81%
Selling, General & Admin $59.40K $53.91K
YoY Change
% of Gross Profit 139.63% 247.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $59.40K $53.91K
YoY Change 225.16% 90.22%
Operating Profit -$16.86K -$32.17K
YoY Change -7.71% 13.51%
Interest Expense $8.118K $7.976K
YoY Change 3.28% 1.33%
% of Operating Profit
Other Income/Expense, Net $0.00 $640.00
YoY Change
Pretax Income -$41.44K -$25.77K
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$41.44K -$25.77K
YoY Change -44.54% -57.34%
Net Earnings / Revenue -44.85% -64.96%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 67.95M shares
Diluted Shares Outstanding 67.95M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.40K $10.17K
YoY Change
Cash & Equivalents $35.40K $10.17K $7.644K
Short-Term Investments
Other Short-Term Assets $3.910K
YoY Change
Inventory
Prepaid Expenses $3.908K $0.00
Receivables $12.04K $13.77K $0.00
Other Receivables $7.400K $8.620K
Total Short-Term Assets $58.74K $32.56K $16.91K
YoY Change -26.32%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $3.168K $3.168K $3.168K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.168K $3.170K $3.167K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $58.74K $32.56K $16.91K
Total Long-Term Assets $3.168K $3.170K $3.167K
Total Assets $61.91K $35.73K $20.07K
YoY Change -12.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $266.1K $245.7K
YoY Change
Accrued Expenses $276.8K $272.6K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.274M $1.268M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.817M $1.786M $1.707M
YoY Change 2.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.817M $1.786M $1.707M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.817M $1.786M $1.707M
YoY Change 2.71%
SHAREHOLDERS EQUITY
Retained Earnings -$8.029M -$7.988M -$7.962M
YoY Change 2.28%
Common Stock $67.95K $67.95K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.755M -$1.751M -$1.687M
YoY Change
Total Liabilities & Shareholders Equity $61.91K $35.73K $20.07K
YoY Change -12.52%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$41.44K -$25.77K
YoY Change -44.54% -57.34%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $6.660K -$1.621K
YoY Change -92.68%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.120K $14.36K
YoY Change 859.83%
NET CHANGE
Cash From Operating Activities 6.660K -$1.621K
Cash From Investing Activities
Cash From Financing Activities 9.120K $14.36K
Net Change In Cash 15.78K $2.528K
YoY Change -143.14%
FREE CASH FLOW
Cash From Operating Activities $6.660K -$1.621K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001172069
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 dei Entity Address Country
EntityAddressCountry
CA
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67946513 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67946513 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67946513 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
333-91190
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
P2 SOLAR, INC.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0234680
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
UNIT 250
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
2411 – 160th Street
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Surrey
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V3S 0C8
CY2023Q2 dei City Area Code
CityAreaCode
778
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
371-3571
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
67946513 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67946513 shares
CY2022Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
CY2023Q2 us-gaap Revenues
Revenues
39667 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
17926 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
21741 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5502 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
34467 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
13635 usd
CY2023Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
13941 usd
CY2022Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
14662 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
53910 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
28341 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-32169 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-28341 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
7976 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
7871 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
13736 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24183 usd
CY2023Q2 us-gaap Other Income
OtherIncome
643 usd
CY2022Q2 us-gaap Other Income
OtherIncome
0 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
6403 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-32054 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-25766 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-60395 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-25766 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-60395 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-37771 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
50163 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63537 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10232 usd
CY2023Q2 ptos Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
CY2022Q2 ptos Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
CY2023Q2 ptos Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67946513 shares
CY2022Q2 ptos Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67946513 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1687077 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-37771 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1750614 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1639129 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
50163 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-60395 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1649362 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-25766 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-60395 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13581 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
CY2023Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-841 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3719 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
20670 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4862 usd
CY2023Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2273 usd
CY2022Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
15021 usd
CY2023Q2 ptos Increase Decrease In Management Fees Payables
IncreaseDecreaseInManagementFeesPayables
13941 usd
CY2022Q2 ptos Increase Decrease In Management Fees Payables
IncreaseDecreaseInManagementFeesPayables
14662 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1621 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22130 usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24263 usd
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5158 usd
CY2023Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
14372 usd
CY2022Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
3662 usd
CY2023Q2 ptos Repayments Debt Of Promissory Note
RepaymentsDebtOfPromissoryNote
17873 usd
CY2022Q2 ptos Repayments Debt Of Promissory Note
RepaymentsDebtOfPromissoryNote
0 usd
CY2023Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
22341 usd
CY2022Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14359 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1496 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10210 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14774 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2528 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5860 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8208 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10172 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2348 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q4 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
110000 usd
CY2022Q4 us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
0.03
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
13774 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7987629 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-25766 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q2 us-gaap Cash
Cash
10172 usd
CY2023Q1 us-gaap Cash
Cash
7644 usd
CY2023Q2 us-gaap Other Receivables
OtherReceivables
8615 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
9263 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
245727 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
219896 usd
CY2023Q2 us-gaap Goodwill
Goodwill
3168 usd
CY2023Q2 us-gaap Revenues
Revenues
39667 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
17926 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
550840 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
544812 usd
CY2023Q2 ptos Less Non Current Portion Of Promissory Note Payable
LessNonCurrentPortionOfPromissoryNotePayable
0 usd
CY2023Q1 ptos Less Non Current Portion Of Promissory Note Payable
LessNonCurrentPortionOfPromissoryNotePayable
0 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
550840 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
544812 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
21741 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q1 ptos Business Acquisitions Purchase Price Estimation
BusinessAcquisitionsPurchasePriceEstimation
0.25 pure
CY2023Q2 us-gaap Purchase Obligation
PurchaseObligation
0 usd
CY2023Q2 ptos Bank Consideration Paid
BankConsiderationPaid
6 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
6 usd
CY2023Q2 ptos Shareholder Loan Payable
ShareholderLoanPayable
-2196 usd
CY2023Q2 ptos Gst Payable During Acquisition
GstPayableDuringAcquisition
-977 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
3173 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-3168 usd
CY2023Q2 us-gaap Goodwill
Goodwill
3168 usd
CY2023Q2 us-gaap Notes Issued1
NotesIssued1
22659 usd
CY2023Q2 us-gaap Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
0.05 pure
CY2023Q2 us-gaap Interest Expense
InterestExpense
7976 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
7871 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
272640 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
264482 usd
CY2023Q2 ptos Accrued Management Salary To Related Party
AccruedManagementSalaryToRelatedParty
715852 usd
CY2023Q1 ptos Accrued Management Salary To Related Party
AccruedManagementSalaryToRelatedParty
676706 usd
CY2023Q2 ptos Due To Related Party Current
DueToRelatedPartyCurrent
717136 usd
CY2023Q1 ptos Due To Related Party Current
DueToRelatedPartyCurrent
677962 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67946513 shares

Files In Submission

Name View Source Status
0001640334-23-001561-index-headers.html Edgar Link pending
0001640334-23-001561-index.html Edgar Link pending
0001640334-23-001561.txt Edgar Link pending
0001640334-23-001561-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ptos-20230630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ptos-20230630_cal.xml Edgar Link unprocessable
ptos-20230630_def.xml Edgar Link unprocessable
ptos-20230630_lab.xml Edgar Link unprocessable
ptos_10q.htm Edgar Link pending
ptos_ex311.htm Edgar Link pending
ptos_ex312.htm Edgar Link pending
ptos_ex321.htm Edgar Link pending
ptos_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ptos-20230630_pre.xml Edgar Link unprocessable
ptos_10q_htm.xml Edgar Link completed